News

These findings appear to contradict earlier observational studies, which found sustained use of non-steroidal anti-inflammatory drugs (NSAIDs) may have a protective effect against Alzheimer's disease. The trial involved

Nova22007 is a cyclosporine A ophthalmic product intended to be used to treat patients suffering from moderate-to-severe dry eye syndrome. As part of the trial approval, the FDA

In a separate agreement, the companies will also collaborate on the research, development and commercialization of a Pfizer discovery program which includes advanced preclinical compounds with potential applications

Roche said supply significantly exceeds current Tamiflu orders, and so it is tailoring its production schedule to this current demand. Roche has orders from governments amounting to about

The federal court said the offer had been made in the expectation that the pharmacy benefit manager would promote the company's drug over rival drugs on the market.

“This study is important because it shows the benefit of a new approach to treat this deadly disease,” said Dr Malcolm Moore, chief of Medical Oncology and Hematology

The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) is reviewing the issue and has been advised that medication containing the chemicals ephedrine and pseudoephedrine in branded products

The pathway is known as NF-kB and a variety of chemotherapies and cytokines used in the treatment of cancer are known to activate its signaling. The current studies

The indication was strengthened from “slowing” to “inhibiting” the progression of structural damage in adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate